New patents for week 37 year 2017
14 new patents,
Sr no
|
Patent number
|
name
|
company
|
INDICATION
|
REMARKS, WAIT FOR STR TO APPEAR
|
1
|
US-20170260157
|
POMALIDOMIDE
|
APICORE
|
MULTIPLE MYELOMA
| |
2
|
WO-2017156403
|
ELAMIPRETIDE
|
STEALTH
|
Acute coronary syndrome; Age related macular degeneration; Cardiac failure; Corneal dystrophy; Diabetic macular edema; Lebers hereditary optic atrophy
|
(D-Arg-dimethylTyr-Lys-Phe-
|
3
|
WO-2017156398
|
VENETOCLAX
|
TEVA
| Chronic lymphocytic leukemia | |
4
|
WO-2017154021
|
LURASIDONE
|
ZCL
|
Schizophrenia
| |
5
|
WO-2017154019
|
CARMUSTINE
|
MSN
| Brain tumor; Hodgkins disease; Multiple myeloma; Non-Hodgkin lymphoma | |
6
|
WO-2017154016
|
SACUBITRIL, VALSARTAN, VORTIXETINE
|
MSN
| Cardiac failure; Major depressive disorder | |
7
|
WO-2017153958
|
OLAPARIB
|
LUPIN
|
CANCER
| |
8
|
WO-2017153471
|
ELUXADOLINE
|
EUTICALS
|
Irritable bowel syndrome
| |
9
|
WO-2017152972
|
VINORELBINE
|
SYNBIAS
| Breast tumor; Non-small-cell lung cancer | |
10
|
WO-2017152858
|
CERITINIB
|
CRYSTAL
| Metastatic non small cell lung cancer; Non-small-cell lung cancer | |
11
|
WO-2017152846
|
VELIPARIB
|
CRYSTAL
| Brain tumor; Colon tumor; Metastatic breast cancer; Stage IV melanoma | |
12
|
WO-2017152755
|
SACUBITRIL
|
SHENZEN
| Cardiac failure | |
13
|
WO-2017152677
|
OBETICHOLIC ACID
|
SCHENZEN
| Primary biliary cirrhosis | |
14
|
US-20170260247
|
DEGARELIX
|
CHENGDU
| Prostate tumor | |
PATENT WK 37 YR 2017
New patents for New week number 36 year 2017
12new patents,
Sr no
|
Patent number
|
name
|
company
|
INDICATION
|
REMARKS, WAIT FOR STR TO APPEAR
|
1
|
WO-2017148325
|
LORLATINIB
|
SHENZHEN
|
CANCER
| |
2
|
WO-2017148318
|
BELINOSTAT
|
SHENZEN
|
CANCER
| |
3
|
WO-2017148290
|
TENOFOVIR
|
SHENZEN
|
HEPATITIS B
| |
4
|
EP-0321407
|
REPAGLINID
|
ZAKLADY
| Non-insulin dependent diabetes | |
5
|
EP-03214075
|
CARMUSTINE
|
NERPHARMA
|
Brain tumor; Glioma; Hodgkins disease; Multiple myeloma; Non-Hodgkin lymphoma
| |
6
|
WO-2017149550
|
NILOTINIB
|
MSN
|
Chronic myelocytic leukemia
| |
7
|
WO-2017149420
|
VALACICLOBVIR
|
AUROBINDO
|
Genital herpes; Varicella zoster virus infection
| |
8
|
WO-2017149332
|
MIRABEGRON
|
EIGIS
|
Overactive bladder
| |
9
|
WO-2017149091
|
DESOGESTREL
|
BIONICE
|
Female contraception
| |
10
|
WO-2017148357
|
SACUBITRIL
|
SUNSHINE
|
Cardiac failure
| |
11
|
WO-2017148416
|
MAISTANSINE
|
XDC
|
CANCER
| |
12
|
WO-2017147893
|
POSACONAZOLE
|
ZHEJIANG
|
FINGAL INF
| |
PATENT WK36 YR 2017
New patents for New week number 35 year 2017
Sr no
|
Patent number
|
name
|
company
|
INDICATION
|
REMARKS, WAIT FOR STR TO APPEAR
|
1
| US-20170247356 |
EMPAGLIFLOZIN
|
CADILA
|
DIABETES
| |
2
|
WO-2017145089
|
BOSUTNIB
|
SUN
|
Chronic myelocytic leukemia
| |
3
|
WO-2017145054
|
PALBOCICLIB
|
LUPIN
|
Metastatic breast cancer
| |
4
|
WO-2017145028
|
LEDIPASVIR
|
GLENMARK
|
Hepatitis C virus infection
| |
5
|
WO-2017144734
|
SUGGAMADEX
|
SYNTHON
|
General anesthesia
| |
6
|
WO-2017144709
|
RIAMILOVIR
|
DORING
| Flavivirus infection; Zika virus infection | |
7
|
WO-2017144708
|
RIAMILOVIR
|
DORING
| Flavivirus infection; Zika virus infection | |
8
|
WO-2017144598
|
LORCASERIN
|
ENANTIA
|
Obesity
| |
9
|
WO-2017144423
|
Sofosbuvir
|
HC PHARMA
|
Hepatitis C virus infection
| |
10
|
WO-2017144065
|
THAPSIGARGIN
|
IPALK
| Solid tumor | |
11
|
WO-2017144029
|
NINTEDANIB
|
ZENTIVA
|
Idiopathic pulmonary fibrosis
| |
12
|
WO-2017144010
|
ENTOSPLETINIB
|
CRYSTAL
|
Cancer; Inflammatory disease
| |
13
|
WO-2017143628
|
EZETIMIBE
|
CHANGSHOU
|
Hypercholesterolemia; Hyperlipidemia
| |
14
|
WO-2017143627
|
ALISKIREN
|
CHANGSHOU
|
HYPERTENSION
| |
15
|
WO-2017143842
|
ROCILETINIB
|
SCHENZEN
|
Autoimmune disease; Cancer; Cardiovascular disease; Infectious disease; Inflammatory disease; Metabolic disorder; Viral infection
| |
16
|
WO-2017143836
|
ROXADUSTAT
|
SCHENZEN
|
Anemia; Cancer; Glucose intolerance; Hematological disease
| |
17
|
WO-201714395
|
REBAUDIOSIDE
|
ZHUCHENG
|
sweetener in food, beverages and pharmaceuticals.
|
B
|
PATENT WK 35YR 2017
New patents for New week number 34 year 2017
Sr no
|
Patent number
|
name
|
company
|
INDICATION
|
REMARKS, WAIT FOR STR TO APPEAR
|
1
|
WO-2017141202
|
EMPAGLIFLOZIN
|
LUPIN
|
DIABETES
| |
2
|
WO-2017142804
|
VERUBECESTAT
|
MERCK
|
Alzheimers disease; Mild cognitive impairment
| |
3
|
WO-2017141193
|
SACUBITRIL
|
SUN
|
Cardiac failure
| |
4
|
WO-2017140283
|
OLAPARIB
|
ZENTIVA
|
Fallopian tube cancer; Metastatic ovary cancer; Ovary tumor; Peritoneal tumor
| |
5
|
WO-2017140251
|
EZETIMIBE
|
CHANGZHOU
|
Familial hypercholesterolemia; Hypercholesterolemia; Sitosterolemia
| |
6
|
WO-2017140183
|
GALETERONE
|
SCHENZEN
|
Prostate tumor
| |
7
|
WO-2017139971
|
ARIPIPRAZOLE
|
NORATECH
|
Autism; Bipolar disorder; Major depressive disorder; Mania; Schizophrenia; Tourette syndrome
| |
8
|
WO-2017140073
|
CEFATHIAMIDINE
|
HAINAN
|
Bacterial infection; Bacterial respiratory tract infection; Endocarditis; Hepatobiliary disease; Otorhinolaryngological infection; Sepsis; Urinary tract infection
| |
9
|
WO-2017140074
|
CEFMENOXIME
|
HAINAN
|
Bacterial infection
| |
PATENT 34 YR2017
No comments:
Post a Comment